Prof. Paolo Bossi
Medical Oncology
Brescia, Lombardia, Italy
KEYNOTE LECTURE:
“Immunotherapy for Head & Neck SCC: Present and Future.”
KEYNOTE LECTURE: “Immunotherapy for Head & Neck SCC: Present and Future.”
Paolo Bossi is a Medical Oncologist, Associate Professor at the Università degli Studi di Brescia and ASST Spedali Civili di Brescia.
He is involved in several institutional research activities on head and neck cancer, and on skin cancer (squamous and basal cell cancer and adnexal cancer), from translational research (gene expression, next generation sequencing) to assessment of quality of life and value based medicine.
He is particularly dedicated to rare cancer including paranasal sinus cancers, nasopharyngeal cancer and salivary gland cancer. He has a strong commitment to supportive care, specifically for what concerns mucositis induced by cancer therapies, since he is the chair of Mucositis study group at MASCC (Multinational Association of Supportive Care in Cancer). He is also president of NICSO (Network Italiano di Cure di Supporto in Oncologia). He is involved in research and education projects of ESMO e EORTC. He has obtained several fundings for studies of indipendent research (Governament research, AIRC, ERA Personalized Medicine) and for Investigator Initiated trials (in oral cavity cancer, larynx, nasopharynx, paranasal sinus and in supportive care).
Prof. Kenneth Hu
Radiation Oncology
Mount Sinai Beth Israel, St. Luke’s-Roosevelt & New York Eye and Ear Infirmary
ORATION
“Treatment De-escalation for Oropharynx Cancer in the Human Papilloma Virus Era.”
ORATION “Treatment De-escalation for Oropharynx Cancer in the Human Papilloma Virus Era.”
Dr. Hu’s clinical interests include the research and treatment of head and neck as well as gastrointestinal tumors. He has trained extensively in brachytherapy procedures for head and neck cancers and is involved in the development of the radiation oncology department’s intraoperative radiation therapy program (IORT). He has an internationally recognized reputation in head and neck cancer and holds leadership positions in the American Society for Therapeutic Radiology and Oncology, International Society of Intraoperative Radiotherapy as well as New York Head and Neck Society. He serves on the American Board of Radiology and is a reviewer for multiple academic journals.
Prof. Bulent Cekic
Associate Professor of Radiology,
Chief, Interventional Radiology,
Antalya Research and Training Hospital, Antalya
KEYNOTE LECTURE
“Non-surgical Ablation for Thyroid lesions”
KEYNOTE LECTURE “Non-surgical Ablation for Thyroid lesions”
Dr. Bülent Çekiç is a leading expert in thyroid thermal ablation, specifically microwave and radiofrequency ablation. He has treated over 3500 cases using these methods since 2013, and has published 8 articles on the topic in Pubmed.
In recent years, he has also begun offering thyroid artery embolization as a non-surgical treatment option for plunging and diffuse goitre, and has treated
Prof. Abbas Agaimy
Professor & Deputy Director, Institute of Pathology,
Friedrich‐Alexander‐University Erlangen‐Nuremberg,
University Hospital, Erlangen, Germany
KEYNOTE LECTURE:
“The evolving story of Head & Neck Pathology: Where morphology meets genetics”.
KEYNOTE LECTURE: “The evolving story of Head & Neck Pathology: Where morphology meets genetics”.
Authored/co‐authored more than 600 PubMed‐listed publications and more than 40 Book chapters including 31 WHO chapters on classification of tumors of different organ systems.
Rated among the top 2% most‐cited scientists across the globe (published by Stanford University, 2021), ranking 18 among the top 50 scientists in pathology in the country.
His Head & Neck Cancer research focuses on salivary gland and sinonasal tract neoplasms, Soft tissue tumors / sarcoma and undifferentiated malignancies with focus on dedifferentiated melanoma.
Prof. Ricardo l Carrau
Professor, Department of Otolaryngology – Head & Neck Surgery
The Ohio State University Wexner Medical Center & The James Cancer Center, USA
KEYNOTE LECTURE:
“Technological Advances in Skull Base Surgery”
KEYNOTE LECTURE: “Technological Advances in Skull Base Surgery”
Dr Carrau is Director of the Comprehensive Skull Base Surgery Program and Co-director of the research and education laboratory ALT-VISION (Anatomy Laboratory Toward Visuotial Innovations in Otolaryngology and Neurosurgery). He also organizes, develops and promotes the sialendoscopy salivary disorders program and the swallowing disorders rehabilitation program. In the past, he served at the University Of Pittsburgh Medical Center, as the Medical Director of the Swallowing Disorders Center, Director of the Division of Maxillofacial Trauma, and as a member of the Division of Rhinology and Allergy, Division of Head & Neck Oncologic Surgery, Division of Skull Base Surgery, and the Minimally Invasive Neurosurgery Center. Dr Carrau has authored more than 450 publications and belongs to multiple professional organizations that match his clinical interests.
Dr Carrau’s clinical interests are diverse and include traditional and endoscopic skull base surgery, head and neck oncology, swallowing disorders, disorders of the salivary glands and sialendoscopy, disorders of the paranasal sinuses, and endoscopic sinus surgery and laryngotracheal stenosis. Dr Carrau is a recognized world expert in skull base surgery and a pioneer in endoscopic skull base surgery.
Dr. Daisuke Nishikawa (MD, PhD)
Department of Head and Neck Surgery, Aichi Cancer Center (Nagoya, Japan)
KEYNOTE LECTURE:
“Session on Recurrent / Metastatic HNSCC: Results of photoimmunotherapy in HNSCC.”
“Session on Recurrent / Metastatic HNSCC: Results of photoimmunotherapy in HNSCC.”
Serving as a sub‐investigator in the Phase III Trial of photoimmunotherapy (PIT) (ASP‐1929‐301 study). Since the marketing approval of Photoimmunotherapy in Japan in January 2021, he has been a member of the PIT operating committee until February 2023, working diligently to ensure that PIT is implemented safely and effectively in clinical practice.
Dr. Ryuhei Okada (MD, PhD)
Specially Appointed Assistant Professor
Department of Head and Neck Surgery, Tokyo Medical and Dental University (Tokyo, Japan)
KEYNOTE LECTURE:
“Near-infrared photoimmunotherapy: Translational research and clinical application.”
KEYNOTE LECTURE: “Near-infrared photoimmunotherapy: Translational research and clinical application.”
Dr. Okada is a Board‐Certificate Head and Neck Surgeon in Japan. While engaging in clinical practice, he is also conducting clinical and basic research. His research and clinical interest is on near‐infrared photoimmunotherapy (NIR‐PIT, AlluminoxTM), which was originally developed by Dr. Hisataka Kobayashi at National Cancer Institute (NCI), USA. He researched NIR‐PIT for 3 years at NCI
Dr. Kobayashi lab as a postdoctoral fellow, and continued the research after returning to Japan. NIR‐PIT/Alluminox has regulatory approval for head and neck cancer in Japan since 2021. He was selected as a member of the Alluminox Steering Committee, which is governed by the Japan Society for Head and Neck Surgery.